ClinConnect ClinConnect Logo
Search / Trial NCT07044895

Diode Laser Photocoagulation With Immediate Implant Placement

Launched by HAMS HAMED ABDELRAHMAN · Jun 22, 2025

Trial Information

Current as of July 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to place dental implants right after removing a tooth in the upper front area of the mouth, which is important for a natural-looking smile. The study is looking at whether using a special laser treatment called diode laser photocoagulation, along with a customized healing part, can help improve healing of the bone and gum tissue around the implant. This approach aims to shorten treatment time, make the process more comfortable, and help the gums and bone stay healthy to prevent infections.

People who might be eligible for this trial are adults who need to have a severely damaged or infected upper front tooth removed and replaced immediately with an implant. To join, participants should have good oral hygiene and a specific type of tooth socket after extraction that allows for immediate implant placement. People with certain conditions like damaged bone, heavy smoking habits, or certain medical treatments affecting bone healing would not be eligible. Participants can expect to undergo the tooth removal and implant placement with the laser treatment to see if this method helps improve healing and long-term success of the implant.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with non-restorable maxillary teeth in the aesthetic zone are indicated for extraction and subsequent immediate implant placement, including those with:
  • A severely carious tooth that cannot be restored.
  • Pulpal necrosis or irreversible pulpitis that is not amenable to endodontics.
  • Periodontally involved teeth with grade 2 mobility or above.
  • Teeth with root caries that can't be restored.
  • Patients with an extraction socket Type I.
  • A good standard of oral hygiene.
  • Exclusion Criteria:
  • Patients with extraction socket Type II or III, with buccal plate defects.
  • Absence of at least 2 mm of bone apical to the extraction socket
  • tooth ankylosis.
  • Patients with deciduous teeth.
  • Heavy smokers.
  • Systemic conditions
  • History of oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months

About Hams Hamed Abdelrahman

Hams Hamed Abdelrahman is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on ethical practices and regulatory compliance, the organization prioritizes patient safety and data integrity in all its clinical trials. Leveraging a diverse team of experienced professionals, Hams Hamed Abdelrahman collaborates with healthcare providers and research institutions to facilitate the development of new therapies and interventions that address unmet medical needs across various therapeutic areas.

Locations

Beirut, , Lebanon

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported